Azacitidine AML
由 L Pleyer 著作 · 2017 · 被引用 39 次 — In 2008, azacitidine was approved by the European Medicines Agency (EMA) for the treatment of AML patients with 20%–30% bone marrow (BM) blasts, ... ,由 AH Wei 著作 · 2020 · 被引用 63 次 — Abstract Background Although induction chemotherapy results in remission in many older patients with acute myeloid leukemia (AML), ... ,由 CD DiNardo 著作 · 2020 · 被引用 385 次 — Older patients with acute myeloid leukemia (AML) have a dismal prognosis, even after treatment with a hypomethylating agent. Azacitidine ... ,Azacitidine was also associated with improved OS in patients with AML-MRC, consistent with findings that azacitidine significantly improves OS in patients with ... ,2021年1月25日 — Azacitidine實際上是擁有10年以上歷史的AML藥物，其屬於一種低度甲基化(hypomethylating drug)藥物，透過調控細胞內DNA的甲基化標誌達成治療。過去以商品 ... ,由 AC Schuh 著作 · 2017 · 被引用 37 次 — Azacitidine is recommended front-line treatment for older patients with acute myeloid leukemia (AML) who are not candidates for intensive treatment regimens, ... ,由 G Huls 著作 · 2019 · 被引用 82 次 — The prevention of relapse is the major therapeutic challenge in older patients with acute myeloid leukemia (AML) who have obtained a ... ,由 B Oran 著作 · 2020 · 被引用 31 次 — This study investigated the efficacy and safety of azacitidine maintenance ... with acute myeloid leukemia/myelodysplastic syndrome (AML/MDS). ,由 H Dombret 著作 · 2015 · 被引用 824 次 — ... phase 3 trial evaluated azacitidine efficacy and safety vs conventional care ... acute myeloid leukemia (AML) with >30% bone marrow blasts. ,Azacitidine is a chemotherapy drug, which is used for the ... cell transplant, with acute myeloid leukaemia (AML), ... How is azacitidine administered?
| 相關軟體 HMA! Pro VPN 資訊 | |
|---|---|
 Azacitidine AML 相關參考資料
Azacitidine for Front-Line Therapy of Patients with AML - NCBI
由 L Pleyer 著作 · 2017 · 被引用 39 次 — In 2008, azacitidine was approved by the European Medicines Agency (EMA) for the treatment of AML patients with 20%–30% bone marrow (BM) blasts, ... https://www.ncbi.nlm.nih.gov Oral Azacitidine Maintenance Therapy for Acute Myeloid ...
由 AH Wei 著作 · 2020 · 被引用 63 次 — Abstract Background Although induction chemotherapy results in remission in many older patients with acute myeloid leukemia (AML), ... https://www.nejm.org Azacitidine and Venetoclax in Previously Untreated Acute ...
由 CD DiNardo 著作 · 2020 · 被引用 385 次 — Older patients with acute myeloid leukemia (AML) have a dismal prognosis, even after treatment with a hypomethylating agent. Azacitidine ... https://www.nejm.org International phase 3 study of azacitidine vs conventional care ...
Azacitidine was also associated with improved OS in patients with AML-MRC, consistent with findings that azacitidine significantly improves OS in patients with ... https://ashpublications.org 首款獲批AML維持療法！BMS口服劑型Onureg公布臨床
2021年1月25日 — Azacitidine實際上是擁有10年以上歷史的AML藥物，其屬於一種低度甲基化(hypomethylating drug)藥物，透過調控細胞內DNA的甲基化標誌達成治療。過去以商品 ... https://store.gbimonthly.com Azacitidine in adult patients with acute myeloid leukemia
由 AC Schuh 著作 · 2017 · 被引用 37 次 — Azacitidine is recommended front-line treatment for older patients with acute myeloid leukemia (AML) who are not candidates for intensive treatment regimens, ... https://pubmed.ncbi.nlm.nih.go Azacitidine maintenance after intensive chemotherapy ...
由 G Huls 著作 · 2019 · 被引用 82 次 — The prevention of relapse is the major therapeutic challenge in older patients with acute myeloid leukemia (AML) who have obtained a ... https://pubmed.ncbi.nlm.nih.go A phase 3 randomized study of 5-azacitidine maintenance vs ...
由 B Oran 著作 · 2020 · 被引用 31 次 — This study investigated the efficacy and safety of azacitidine maintenance ... with acute myeloid leukemia/myelodysplastic syndrome (AML/MDS). https://pubmed.ncbi.nlm.nih.go International phase 3 study of azacitidine vs ... - PubMed
由 H Dombret 著作 · 2015 · 被引用 824 次 — ... phase 3 trial evaluated azacitidine efficacy and safety vs conventional care ... acute myeloid leukemia (AML) with >30% bone marrow blasts. https://pubmed.ncbi.nlm.nih.go Azacitidine for Acute Myeloid Leukaemia (AML)
Azacitidine is a chemotherapy drug, which is used for the ... cell transplant, with acute myeloid leukaemia (AML), ... How is azacitidine administered? https://media.leukaemiacare.or |